TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23880960

Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg/day
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Resistant starch 30 g/day
Number of subjects: 937

Group type: COMPARATOR
Intervention: Control (no aspirin or resistant starch)
Number of subjects: 937
Study: 20659577

Group type: EXPERIMENTAL
Intervention: Combined treatment with formoterol (FOR) 12 μg BID plus tiotropium (TIO) 18 μg QD
Number of subjects: 255

Group type: COMPARATOR
Intervention: Tiotropium (TIO) alone 18 μg QD
Number of subjects: 255
Study: 19812401

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg daily for 6 weeks
Number of subjects: 216

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 216
Study: 17967584

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily
Number of subjects: 12064

Group type: EXPERIMENTAL
Intervention: Folic acid 2 mg plus vitamin B12 1 mg daily
Number of subjects: 12064

Group type: COMPARATOR
Intervention: Matching placebo for homocysteine lowering
Number of subjects: 12064

Group type: COMPARATOR
Intervention: Simvastatin 20 mg daily
Number of subjects: 12064

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 12064
Study: 15479217

Group type: EXPERIMENTAL
Intervention: Gliclazide MR (30-120 mg) once daily
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Gliclazide MR in combination therapy
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Gliclazide MR
Number of subjects: 800
Study: 11242646

Group type: EXPERIMENTAL
Intervention: High-dose group: MMC at 8 mg/m2 on the day of surgery, and in weeks 4, 10, 16, and 22 after surgery; 6 capsules of UFT (600 mg in tegafur) daily for 6 months.
Number of subjects: 1410

Group type: COMPARATOR
Intervention: Low-dose group: MMC at 8 mg/m2 on the day of surgery; 3 capsules of UFT (300 mg in tegafur) daily for 6 months.
Number of subjects: 1410

Group type: EXPERIMENTAL
Intervention: High-dose group
Number of subjects: 1410

Group type: COMPARATOR
Intervention: Low-dose group
Number of subjects: 1410
Study: 9564282

Group type: EXPERIMENTAL
Intervention: Prophylactic inspiratory muscle training (IMT) using a threshold trainer for 30 min/day for 2 weeks, 1 month before operation (group A)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham training (group B)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Prophylactic inspiratory muscle training (IMT)
Number of subjects: 84
Study: 7996525

Group type: EXPERIMENTAL
Intervention: Programmable subcutaneous infusion pump with terbutaline, adjusted to control uterine contraction frequency to < or = 4 contractions per hour.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral terbutaline, average of 6.5 mg every four to six hours.
Number of subjects: 32
Study: 3396249

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (100 mg IM bi-weekly for six months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31356008

Group type: EXPERIMENTAL
Intervention: Serenoa repens extract (ESR - Permixon) 320 mg capsules per day for two years
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mathematical models built using predictive analytics
Number of subjects: 155
Study: 28367765

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001 (6×10^9 colony-forming units)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423
Study: 25817289

Group type: EXPERIMENTAL
Intervention: Rice bran extract containing acylated steryl glucosides (RB‐ASG)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 24012053

Group type: EXPERIMENTAL
Intervention: 5-day course of amoxicillin/clavulanic acid 625 mg orally every 8 h for 4 days after 24 h of intravenous administration
Number of subjects: 62

Group type: COMPARATOR
Intervention: 1-day course of amoxicillin/clavulanic acid 1.2 g intravenously for 24 h followed by oral placebo
Number of subjects: 62
Study: 22082795

Group type: EXPERIMENTAL
Intervention: Compression Garments (CGs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Running Shorts
Number of subjects: 25
Study: 20027661

Group type: EXPERIMENTAL
Intervention: RVOT pacing
Number of subjects: 96

Group type: COMPARATOR
Intervention: RVA pacing
Number of subjects: 96
Study: 16462483

Group type: EXPERIMENTAL
Intervention: Neurolysis in situ
Number of subjects: 44

Group type: COMPARATOR
Intervention: Submuscular transposition
Number of subjects: 44
Study: 15000513

Group type: EXPERIMENTAL
Intervention: Acamprosate (1.998 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 11777099

Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin for 5 days
Number of subjects: 25
Study: 9135305

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Thiopentone and Isoflurane)
Number of subjects: 20
Study: 7908821

Group type: EXPERIMENTAL
Intervention: isoflurane
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: sevoflurane
Number of subjects: 86

Group type: COMPARATOR
Intervention: discontinuation of both anaesthetics
Number of subjects: 86
Study: 3282069

Group type: EXPERIMENTAL
Intervention: Participation of volunteer clinical faculty members in education research projects
Number of subjects: 76
Study: 31714531

Group type: EXPERIMENTAL
Intervention: CABG in young patients
Number of subjects: 175

Group type: COMPARATOR
Intervention: CABG in older patients (control group)
Number of subjects: 175
Study: 28775674

Group type: EXPERIMENTAL
Intervention: Individualized fluid plans (IFPs)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ad libitum fluid ingestion (CON)
Number of subjects: 11
Study: 24959663

Group type: EXPERIMENTAL
Intervention: Ferrous asparto glycinate
Number of subjects: 73

Group type: COMPARATOR
Intervention: Ferrous ascorbate
Number of subjects: 73
Study: 22696144

Group type: EXPERIMENTAL
Intervention: Group LM (19 ml of 0.25% levobupivacaine and 1 ml of 15% magnesium sulphate)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Group LM
Number of subjects: 107

Group type: COMPARATOR
Intervention: Group L (20 ml of 0.25% levobupivacaine)
Number of subjects: 107
Study: 21666991

Group type: EXPERIMENTAL
Intervention: Exposure to blue light followed by red light
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exposure to red light followed by blue light
Number of subjects: 12

Group type: COMPARATOR
Intervention: Exposure to red light (previous study)
Number of subjects: 12
Study: 17937959

Group type: EXPERIMENTAL
Intervention: 4 mg fesoterodine
Number of subjects: 836

Group type: EXPERIMENTAL
Intervention: 8 mg fesoterodine
Number of subjects: 836

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 836
Study: 15731540

Group type: EXPERIMENTAL
Intervention: Mucosal protection (teprenone 150 mg/day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Histamine2-receptor antagonist (ranitidine 300 mg/day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (rabeprazole 10 mg/day)
Number of subjects: 210
Study: 11755937

Group type: EXPERIMENTAL
Intervention: tibolone 2.5 mg/day (n=20)
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.625 mg/day conjugated equine oestrogens plus continuous medroxyprogesterone acetate 5 mg/day (n=23)
Number of subjects: 43
Study: 9652276

Group type: EXPERIMENTAL
Intervention: In-line intravenous filters
Number of subjects: 88

Group type: COMPARATOR
Intervention: No in-line intravenous filters
Number of subjects: 88
Study: 7808565

Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg (slow-release formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2675302

Group type: EXPERIMENTAL
Intervention: Low-dose antacid regimen
Number of subjects: 47
Study: 4406985

Group type: EXPERIMENTAL
Intervention: Lillehei Kaster pivoting disc valve
Number of subjects: 68

Group type: COMPARATOR
Intervention: Bjork Shiley tilting disc valve
Number of subjects: 68
Study: 31913908

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 0
Study: 29667598

Group type: EXPERIMENTAL
Intervention: MR-guided transcranial focused ultrasound (FUS) at 650 kHz
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: MR-guided transcranial focused ultrasound (FUS)
Number of subjects: 128
Study: 26118386

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (4 g intravenously then 1 g/h for 6 h)
Number of subjects: 289
Study: 24781936

Group type: EXPERIMENTAL
Intervention: Visual Field Reading Center evaluation of baseline visual fields
Number of subjects: 165
Study: 22695134

Group type: EXPERIMENTAL
Intervention: Weekly UV-B in a tanning bed (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1520-IU/d vitamin D supplement (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 30
Study: 21036840

Group type: EXPERIMENTAL
Intervention: Structured observation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pre-observation days
Number of subjects: 45
Study: 18946298

Group type: EXPERIMENTAL
Intervention: 7 mg spinal bupivacaine with intravenous phenylephrine infusion (0.25 microg . kg(‐1) . min(‐1))
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10 mg spinal bupivacaine with intravenous placebo infusion
Number of subjects: 80
Study: 15671072

Group type: EXPERIMENTAL
Intervention: Cyclosporin microemulsion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclosporin plus metabolites
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclosporin metabolites AM1, AM9, AM1c, AM4n
Number of subjects: 20
Study: 12824967

Group type: EXPERIMENTAL
Intervention: Immediate colposcopy
Number of subjects: 3488

Group type: EXPERIMENTAL
Intervention: HPV triage strategy
Number of subjects: 3488

Group type: EXPERIMENTAL
Intervention: Conservative management strategy (repeat cytology at HSIL threshold)
Number of subjects: 3488
Study: 11938811

Group type: EXPERIMENTAL
Intervention: Yimai Jiangya extract (YMJYE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Captopril (control)
Number of subjects: 68
Study: 8857917

Group type: EXPERIMENTAL
Intervention: Medium cholesterol diet (350 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High cholesterol diet (650 mg)
Number of subjects: 30
Study: 1638340

Group type: EXPERIMENTAL
Intervention: Trichlormethiazide (4 mg/day)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control (no treatment with close follow-up)
Number of subjects: 175
Study: 6594721

Group type: EXPERIMENTAL
Intervention: 0.4 mg PGE2 gel placed retroamnially by means of a balloon catheter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.4 mg PGE2 applied endocervically
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5 mg PGE2 applied endocervically
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 mg PGE2 placed intravaginally in form of a single vaginal tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (only vaginal examination)
Number of subjects: 0
Study: 30892283

Group type: EXPERIMENTAL
Intervention: Navigation group (preoperative virtual planning)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-navigation group (no preoperative virtual planning)
Number of subjects: 29
Study: 29242281

Group type: EXPERIMENTAL
Intervention: Osimertinib 80 mg once daily
Number of subjects: 419

Group type: COMPARATOR
Intervention: Chemotherapy (control)
Number of subjects: 419
Study: 26892451

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Local Anesthesia with Sedation (non-GA)
Number of subjects: 490
Study: 25522424

Group type: EXPERIMENTAL
Intervention: Catecholamine depletion with alpha‐methyl‐para‐tyrosine (AMPT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Catecholamine depletion
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Standardized breakfast (before and after)
Number of subjects: 47
Study: 22278334

Group type: EXPERIMENTAL
Intervention: CG100649 (2 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CG100649 (8 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 21125532

Group type: EXPERIMENTAL
Intervention: PRISM (Pictorial Representation of Illness and Self Measure)
Number of subjects: 3
Study: 17353132

Group type: EXPERIMENTAL
Intervention: Automatic morphometric cartilage quantification using MRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cartilage Curvature quantification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Joint Space Width (JSW)
Number of subjects: 0
Study: 16288118

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 13388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13388
Study: 11882552

Group type: EXPERIMENTAL
Intervention: 42 day reducing course of dexamethasone (long course)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 3 day pulsed course of dexamethasone (pulse course)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both courses of dexamethasone
Number of subjects: 76
Study: 10075616

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone, 200 microg twice daily
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Oral montelukast, 10 mg once daily at bedtime
Number of subjects: 895

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 895
Study: 7734138

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of tyramine to raise systemic blood pressure
Number of subjects: 30
Study: 1755532

Group type: COMPARATOR
Intervention: Patient Controlled Analgesia (PCA) with morphine (2 mg bolus, lock-out 5 min in recovery/intensive care, 15 min in surgical ward)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Epidural Bupivacaine + Morphine (EBM) with bupivacaine (0.25%) and morphine (60 micrograms/ml) infused via epidural catheter for approximately 72 hours
Number of subjects: 292

Group type: COMPARATOR
Intervention: Epidural Morphine (EM) with morphine (0.05 mg/kg in 10 ml saline) injected on request up to the 3rd postoperative day
Number of subjects: 292
Study: 6120272

Group type: EXPERIMENTAL
Intervention: Sulphinpyrazone 400 mg twice daily
Number of subjects: 727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study: 31794936

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 75 U
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 100 U
Number of subjects: 184

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 184
Study: 31063659

Group type: EXPERIMENTAL
Intervention: Fluid Immersion Simulation System (FIS)
Number of subjects: 40
Study: 29610038

Group type: EXPERIMENTAL
Intervention: GP education session
Number of subjects: 291
Study: 26595551

Group type: EXPERIMENTAL
Intervention: Influenza vaccine at the time of infliximab infusion
Number of subjects: 137

Group type: COMPARATOR
Intervention: Influenza vaccine midway between infliximab infusions
Number of subjects: 137
Study: 23471234

Group type: EXPERIMENTAL
Intervention: Recombinant t-PA (0, 40, 200, and 1000 ng/mL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intra-arterial bradykinin infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intra-arterial bradykinin infusion with enalapril
Number of subjects: 20
Study: 20973856

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Bupropion SR + nicotine lozenge
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Nicotine patch + nicotine lozenge
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1504
Study: 18959640

Group type: EXPERIMENTAL
Intervention: CO2 insufflation (CO2i)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Air insufflation (AIRi)
Number of subjects: 96
Study: 16099023

Group type: EXPERIMENTAL
Intervention: Right hemisphere sensitivity to orthographic variables
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Left hemisphere sensitivity to orthographic variables
Number of subjects: 1

Group type: COMPARATOR
Intervention: Dyslexia group
Number of subjects: 1

Group type: COMPARATOR
Intervention: Normal readers
Number of subjects: 1
Study: 12869836

Group type: EXPERIMENTAL
Intervention: BufferGel
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: PRO 2000 Gel
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo (K-Y Jelly)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: BufferGel and PRO 2000 Gel
Number of subjects: 97
Study: 11031076

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solutions (2 and 5% NaCl) and thirsting
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Drinking of free water and overnight application of desmopressin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral water ad libitum
Number of subjects: 8
Study: 9100162

Group type: EXPERIMENTAL
Intervention: Sulodexide (600 lipoprotein-lipase releasing units, intramuscularly, daily for 28 days)
Number of subjects: 15
Study: 8261692

Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg od
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Felodipine PT 2.5 mg bid
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 3511691

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 62
Study: 30041437

Group type: EXPERIMENTAL
Intervention: High-Protein diet with three whole eggs per day (1.4 g protein kg‐1 day‐1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal-Protein diet void of eggs (0.8 g protein kg‐1 day‐1)
Number of subjects: 22
Study: 27936999

Group type: EXPERIMENTAL
Intervention: Single-pill irbesartan/amlodipine combination-based therapy for 12 weeks
Number of subjects: 20
Study: 25166215

Group type: EXPERIMENTAL
Intervention: Pterygopalatine fossa injection with 1% xylocaine and 1:100,000 adrenaline
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (contralateral side without injection)
Number of subjects: 45
Study: 22651920

Group type: EXPERIMENTAL
Intervention: Viewing the film with contextual information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viewing the film without contextual information
Number of subjects: 0
Study: 19238327

Group type: EXPERIMENTAL
Intervention: Talactoferrin 4.5 g/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Talactoferrin 9 g/day
Number of subjects: 36
Study: 18496751

Group type: EXPERIMENTAL
Intervention: Prenatal care for high-risk mothers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prenatal care for low-risk mothers
Number of subjects: 0
Study: 18547273

Group type: EXPERIMENTAL
Intervention: Duodenal levodopa/carbidopa infusion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 18
Study: 15383088

Group type: EXPERIMENTAL
Intervention: Beat-to-beat pulse pressure (PP) variability
Number of subjects: 150
Study: 11442859

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Tracheal Tube (TT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Face Mask (FM)
Number of subjects: 56
Study: 9228961

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural training (CBT)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control programme
Number of subjects: 289
Study: 7913683

Group type: EXPERIMENTAL
Intervention: beta‐adrenoceptor antagonists (beta AA)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: calcium channel blockers (CCB)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: acetylsalicylic acid (ASA)
Number of subjects: 737
Study: 30001179

Group type: EXPERIMENTAL
Intervention: Retrieval-warning group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retrieval-warning group with positive mood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retrieval-warning group with negative mood
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-warning group
Number of subjects: 0
Study: 30346878

Group type: EXPERIMENTAL
Intervention: Photographs created for the research project to match the three populations (Real Health Photos - RHP)
Number of subjects: 1796

Group type: EXPERIMENTAL
Intervention: Messages with only half of the matched RHP images
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Photographs from a stock photograph service
Number of subjects: 1796
Study: 26946730

Group type: EXPERIMENTAL
Intervention: Triple acupuncture method at cervical Jiaji (EX-B 2)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 66
Study: 24318863

Group type: EXPERIMENTAL
Intervention: Planned treatment preceded by pretreatment genetic analysis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: FOLFOX regimen in planned treatment group
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen in planned treatment group
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: FOLFOX regimen in conventional treatment group
Number of subjects: 53

Group type: COMPARATOR
Intervention: FOLFIRI regimen in conventional treatment group
Number of subjects: 53
Study: 22222326

Group type: EXPERIMENTAL
Intervention: Imbalanced asymmetrical center of mass condition (20-kg plate on one side and sixteen 1.25-kg plates on the other side)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Balanced condition (one 20-kg plate on each side)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Imbalanced asymmetrical condition (one 20-kg plate on one side and one 20-kg plate plus a 1.25-kg plate on the other side)
Number of subjects: 35
Study: 20358168

Group type: EXPERIMENTAL
Intervention: Active shock wave stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 12
Study: 17408924

Group type: EXPERIMENTAL
Intervention: Single dose of oral clindamycin (600 mg) administered preoperatively
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Clindamycin administered preoperatively with continued therapy for 5 days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Single dose of oral clindamycin (600 mg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Clindamycin (single dose or 5-day therapy)
Number of subjects: 86
Study: 16306824

Group type: EXPERIMENTAL
Intervention: Diaket
Number of subjects: 45

Group type: COMPARATOR
Intervention: AH Plus
Number of subjects: 45

Group type: COMPARATOR
Intervention: EndoREZ
Number of subjects: 45